MedPath

Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit

Not Applicable
Conditions
Facial Volume
Registration Number
NCT01565915
Lead Sponsor
Medicis Global Service Corporation
Brief Summary

The purpose of this study is to determine if Perlane-L is safe in increasing cheek volume.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
221
Inclusion Criteria
  • Loss of Fullness in Midface Area
  • Other items as identified in the protocol
Exclusion Criteria
  • History of allergy or hypersensitivity to injectable hyaluronic acid gel or lidocaine.
  • Other items as identified in the protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Facial fullness using midface scaleWeek 8

Change in facial fullness using midface scale.

Secondary Outcome Measures
NameTimeMethod
Facial fullness using the midface scaleUp to 12-months post treatment

Change in facial fullness using midface scale.

Subject satisfaction using the GAISUp to 12-months post treatment

Compare treatment satisfaction as compared to no treatment, on the Global Aesthetic Improvement Scale (GAIS)

Aesthetic improvementUp to 12-months post treatment

A subjective assessment of aesthetic improvement post baseline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.